Acute Pulmonary Embolism Giancarlo Agnelli, M.D. and Cecilia Becattini, M.D., Ph.D.
N Engl J Med 2010; 363:266-274
ORGINAL ARTICLES
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
Rachel B. Jones, M.R.C.P., M.D., Jan Willem Cohen Tervaert, M.D., Ph.D., Thomas Hauser, M.D., Raashid Luqmani, D.M., F.R.C.P., F.R.C.P.(E.), Matthew D. Morgan, M.R.C.P., Ph.D., Chen Au Peh, F.R.A.C.P., Ph.D., Caroline O. Savage, Ph.D., F.R.C.P., F.Med.Sci., Mårten Segelmark, M.D., Ph.D., Vladimir Tesar, M.D., Ph.D., Pieter van Paassen, M.D., Ph.D., Dorothy Walsh, B.S.C.N., Michael Walsh, M.D., F.R.C.P.(C.), Kerstin Westman, M.D., Ph.D. and David R.W. Jayne, M.D., F.R.C.P. for the European Vasculitis Study Group
N Engl J Med 2010; 363:211-220
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer Philip W. Kantoff, M.D., Celestia S. Higano, M.D., Neal D. Shore, M.D., E. Roy Berger, M.D., Eric J. Small, M.D., David F. Penson, M.D., Charles H. Redfern, M.D., Anna C. Ferrari, M.D., Robert Dreicer, M.D., Robert B. Sims, M.D., Yi Xu, Ph.D., Mark W. Frohlich, M.D. and Paul F. Schellhammer, M.D. for the IMPACT Study Investigators
N Engl J Med 2010; 363:411-422
